GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iRadimed Corp (NAS:IRMD) » Definitions » Cyclically Adjusted Price-to-FCF

iRadimed (iRadimed) Cyclically Adjusted Price-to-FCF : 64.92 (As of Apr. 29, 2024)


View and export this data going back to 2014. Start your Free Trial

What is iRadimed Cyclically Adjusted Price-to-FCF?

As of today (2024-04-29), iRadimed's current share price is $40.90. iRadimed's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was $0.63. iRadimed's Cyclically Adjusted Price-to-FCF for today is 64.92.

The historical rank and industry rank for iRadimed's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

IRMD' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 47.9   Med: 68.44   Max: 87.26
Current: 66.43

During the past years, iRadimed's highest Cyclically Adjusted Price-to-FCF was 87.26. The lowest was 47.90. And the median was 68.44.

IRMD's Cyclically Adjusted Price-to-FCF is ranked worse than
70.87% of 230 companies
in the Medical Devices & Instruments industry
Industry Median: 42.185 vs IRMD: 66.43

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

iRadimed's adjusted free cash flow per share data for the three months ended in Dec. 2023 was $0.257. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $0.63 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


iRadimed Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for iRadimed's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iRadimed Cyclically Adjusted Price-to-FCF Chart

iRadimed Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 48.43 75.33

iRadimed Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.43 67.86 79.04 72.07 75.33

Competitive Comparison of iRadimed's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, iRadimed's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iRadimed's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, iRadimed's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where iRadimed's Cyclically Adjusted Price-to-FCF falls into.



iRadimed Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

iRadimed's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=40.90/0.63
=64.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iRadimed's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, iRadimed's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.257/129.4194*129.4194
=0.257

Current CPI (Dec. 2023) = 129.4194.

iRadimed Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 0.044 99.695 0.057
201406 0.149 100.560 0.192
201409 0.084 100.428 0.108
201412 -0.083 99.070 -0.108
201503 0.085 99.621 0.110
201506 0.132 100.684 0.170
201509 0.183 100.392 0.236
201512 0.184 99.792 0.239
201603 0.158 100.470 0.204
201606 0.069 101.688 0.088
201609 0.276 101.861 0.351
201612 0.156 101.863 0.198
201703 -0.040 102.862 -0.050
201706 0.010 103.349 0.013
201709 0.141 104.136 0.175
201712 0.107 104.011 0.133
201803 0.130 105.290 0.160
201806 0.121 106.317 0.147
201809 0.055 106.507 0.067
201812 0.281 105.998 0.343
201903 0.047 107.251 0.057
201906 0.198 108.070 0.237
201909 0.247 108.329 0.295
201912 0.301 108.420 0.359
202003 0.078 108.902 0.093
202006 0.050 108.767 0.059
202009 0.098 109.815 0.115
202012 0.191 109.897 0.225
202103 0.061 111.754 0.071
202106 0.271 114.631 0.306
202109 0.250 115.734 0.280
202112 0.252 117.630 0.277
202203 0.079 121.301 0.084
202206 0.096 125.017 0.099
202209 0.268 125.227 0.277
202212 0.203 125.222 0.210
202303 -0.151 127.348 -0.153
202306 0.246 128.729 0.247
202309 0.075 129.860 0.075
202312 0.257 129.419 0.257

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


iRadimed  (NAS:IRMD) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


iRadimed Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of iRadimed's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


iRadimed (iRadimed) Business Description

Traded in Other Exchanges
Address
1025 Willa Springs Drive, Winter Springs, FL, USA, 32708
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold primarily to hospitals and acute care facilities in the United States and internationally.
Executives
Roger E. Susi director, 10 percent owner, officer: CEO, President, Chairman C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
James B Hawkins director C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
Anthony Vuoto director
Monty K Allen director
Hilda Frederique Scharen-guivel director 440 PALM ISLAND SE, CLEARWATER BEACH FL 33767
John Glenn officer: Chief Financial Officer 7900 HOPYARD ROAD, APT 210, PLEASANTON CA 94577
Christopher K. Scott officer: CHIEF FINANCIAL OFFICER & SECR C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
Brent Johnson officer: Exec. VP. Sales & Marketing 4900 HOPYARD RD, SUITE 210, PLEASITAN CA 94588
Steven M. Nardi officer: VP MANUFACTURING C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
Louis S. Waldman officer: CONTROLLER C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
Leslie L Mcdonnell director, officer: Chief Exec Officer & Director 1501 INDUSTRIAL ROAD, SAN CARLOS CA 94070
Francis X. Casey officer: VP OF REG AND QUAL ASSURANCE C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
John K Mccreery officer: Chief Operating Officer IRADIMED CORP, 1025 WILLA SPRINGS BLVD, WINTER SPRINGS FL 32708
Jonathan Kennedy director INTERSIL CORPORATION, 1001 MURPHY RANCH ROAD, MILPITAS CA 95035
Serge Novovich director C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708